RPD:NASDAQRapid7, Inc. Analysis

Rapid7 is trading at $7.51, comfortably above its 20‑day SMA of $7.21 and 50‑day SMA of $6.37, while the MACD remains bullish and the RSI sits at a neutral 54.6, suggesting short‑term technical strength. However, the price is well below the 200‑day SMA of $12.45, indicating long‑term weakness. Valuation metrics show a trailing PE of 21.5 versus an industry average of 32.6 and a forward PE of just 4.8, pointing to relative cheapness, yet the DCF‑derived fair value of $23.40 implies the market is modestly overvalued by about 2.8%. Volatility is high at 71% over the past 30 days, but beta is modest (Fundamentally, Rapid7 holds $670 M in cash against $965 M of debt, resulting in a high debt‑to‑equity ratio that raises balance‑sheet concerns. Nonetheless, the company generates positive free cash flow (~$141 M) and delivers a solid ROE of 19.7% with a modest profit margin of 2.6%. Recent material news is mixed: an investor‑led securities‑fraud investigation adds legal risk, while a Q1 earnings beat, a strategic acquisition of Kenzo Security, and the launch of a new GRC platform highlight growth opportunities. These dynamics create a nuanced outlook that balances technical upside with significant risk factors.